azacitidine and Transfusion Reaction

azacitidine has been researched along with Transfusion Reaction in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Egle, A; Grabmer, C; Greil, R; Jungbauer, C; Leisch, M; Lindlbauer, N; Pleyer, L; Rohde, E; Weiss, L	1
Carbonell, F; Collado, R; Costa, S; Ivars, D; Javier, K; Linares, M; López, M; Luna, I; Orero, MT; Ortiz, S; Pérez, P; Roig, M; Villegas, C	1
Atweh, GF; Fathallah, H; Sutton, M	1

Reviews

1 review(s) available for azacitidine and Transfusion Reaction

Article	Year
Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia? Annals of the New York Academy of Sciences, 2005, Volume: 1054 Topics: Anemia, Sickle Cell; Animals; Azacitidine; Combined Modality Therapy; Drug Approval; Drug Evaluation; Drug Evaluation, Preclinical; Erythropoiesis; Fetal Hemoglobin; Gene Expression; Gene Expression Regulation; Globins; Humans; Hydroxyurea; Iron; K562 Cells; Models, Animal; Papio; Thalassemia; Transfusion Reaction; United States; United States Food and Drug Administration	2005

Article

Year

Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?

Annals of the New York Academy of Sciences, 2005, Volume: 1054

Topics: Anemia, Sickle Cell; Animals; Azacitidine; Combined Modality Therapy; Drug Approval; Drug Evaluation; Drug Evaluation, Preclinical; Erythropoiesis; Fetal Hemoglobin; Gene Expression; Gene Expression Regulation; Globins; Humans; Hydroxyurea; Iron; K562 Cells; Models, Animal; Papio; Thalassemia; Transfusion Reaction; United States; United States Food and Drug Administration

2005

Other Studies

2 other study(ies) available for azacitidine and Transfusion Reaction

Article	Year
Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience. Leukemia research, 2017, Volume: 59 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Erythrocyte Transfusion; Erythrocytes; Female; Humans; Isoantibodies; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Survival Rate; Transfusion Reaction	2017
Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome. Blood transfusion = Trasfusione del sangue, 2017, Volume: 15, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Azacitidine; Erythrocyte Transfusion; Erythrocytes; Female; Humans; Immunization; Male; Middle Aged; Myelodysplastic Syndromes; Transfusion Reaction	2017

Article

Year

Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.

Leukemia research, 2017, Volume: 59

Topics: Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Erythrocyte Transfusion; Erythrocytes; Female; Humans; Isoantibodies; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Survival Rate; Transfusion Reaction

2017

Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome.

Blood transfusion = Trasfusione del sangue, 2017, Volume: 15, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Azacitidine; Erythrocyte Transfusion; Erythrocytes; Female; Humans; Immunization; Male; Middle Aged; Myelodysplastic Syndromes; Transfusion Reaction

2017